logo
Xigem Technologies Secures Funding to Support its EchoDigital Business Unit

Xigem Technologies Secures Funding to Support its EchoDigital Business Unit

Globe and Mail01-04-2025

Toronto, Ontario--(Newsfile Corp. - April 1, 2025) - Xigem Technologies Corporation (CSE: XIGM) (FSE: VZ6) (" Xigem" or the " Company"), is pleased to announce that on March 31, 2025, it entered into a tripartite loan agreement (the " TLA Facility") to provide up to $500,000 in capital to support its EchoDigital business unit through an arrangement that provides funding to a significant customer of the Company (as described below). The parties to the TLA Facility include: the Company, Carnance Inc. (" Carnance") and Physiomed Health Inc. (the " Lender"). The Lender is an entity controlled by Dr. Scott Wilson, a Director of the Company. The sole purpose of of the TLA Facility is to provide Carnance with the further ability to purchase non-commercial passenger cars, light trucks and sport utility/activity vehicles (" Vehicles") inventory for re-sale into the nearly USD18 Billion Canadian used car market, as estimated by Mordor Intelligence (the " Purpose"). Carnance is a customer of the Company which, pursuant to a previously disclosed exclusive ten year royalty and service based management agreement, has been and continues to be obligated to use the Company's EchoDigital asset in all of its sales efforts.
EchoDigital is the Company's proprietary Saas-based, AI employing platform which assists in seamlessly capturing and converting used car consumer leads from traditional sources. EchoDigital can then assess and qualify the leads in part to determine their aptitude, and subsequently match them with a used car dealer's most suitable customer sales representative. EchoDigital has been solely responsible for the Company's growth in its most recent three fiscal quarters.
In addition to the funds being made available to Carnance through the TLA Facility, Brian Kalish, the Company's CEO and a Director arranged for and personally guaranteed a line of credit for Carnance from a financial institution (the " Carnance Line of Credit") in August 2024. The Carnance Line of Credit as with the TLA Facility was arranged with the goal of increasing the Vehicle inventory available to Carnance, as it exclusively employs the Company's EchoDigital asset in line with the Purpose described in this press release. Management expects that the combination of funds from the Carnance Line of Credit and the TLA facility may have a positive impact on Carnance's business and then as a result, on that of the Company. Xigem has no obligations with respect to the Carnance Line of Credit.
The provisions of the TLA include but are not limited to the following:
The Lender agreeing to lend funds to the Company, which shall in turn lend such funds to Carnance for the Purpose described in this press release (and more fully described in the TLA Facility).
The Lender receiving fees paid by the Company as follows: (i) $50,000 satisfied through the issuance of common shares in the capital of the Company, priced at $0.05 per common share and (ii) $50,000 satisfied through the issuance of common share purchase warrants entitling the Lender to acquire additional common shares in the capital of the Company valued at an aggregate of $50,000 at an exercise price of $0.05 per common share, for a 24 month period (collectively, the " Fee Based Shares").
A fee equal to 12.5% of the total value of the loan, paid in cash, in advance, by Carnance.
The Lender receiving a senior ranking security over all of the assets of the Company.
"Our EchoDigital asset has proven itself to be of considerable value to our business and its shareholders. This tripartite loan agreement supported by one of our directors, coupled with my own pledge is anticipated to reinforce Xigem and our ability to support our partners" said Brian Kalish, CEO of Xigem.
All Fee Based Shares will be subject to a four-month and one-day hold period. No new control person of the Company will be created pursuant to the TLA transaction. All shares issued in connection with the TLA will be issued in accordance with the policies of the Canadian Securities Exchange (the "CSE").
Completion of the TLA is subject to customary closing conditions associated with a transaction of its type. It is currently anticipated that closing will take place on or before April 11, 2025. Brian Kalish may be eligible to receive an arrangement fee paid for exclusively by Carnance.
Issuance of the Fee Based Shares would constitute a "related party transaction" as defined in Multilateral Instrument 61-101 - Protection of Minority Securityholders in Special Transactions (" MI 61-101"). Carnance, an entity controlled by an insider of the Company, is anticipated to receive an aggregate of 1,000,000 common shares of the Company due to the issuance of the Fee Based Shares. The Company is relying on the exemptions from the valuation and minority shareholder approval requirements of MI 61-101 contained in sections 5.5(a) and 5.7(1)(a) of MI 61-101, as the fair market value of the participation in the TLA by insiders does not exceed 25% of the market capitalization of the Company, as determined in accordance with MI 61-101.
About Xigem Technologies Corporation
With software capable of improving capacity, productivity, and overall operations for businesses, consumers, and organizations Xigem aims to position itself to become a leading technology provider for the near trillion-dollar remote digital economy. iAgent, the Company's patented technology and EchoDigital, its SaaS automotive shopping platform are intended to provide organizations, businesses, and consumers with the tools necessary to thrive in a vast array of digital working, learning, shopping and treatment environments while the Company continually looks to aggregate a portfolio of innovative technologies capable of disrupting traditional business models.
www.xigemtechnologies.com
Source: https://www.mordorintelligence.com/industry-reports/canada-used-car-market
Further Information
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities, in any jurisdiction in which such offer, solicitation or sale would be unlawful.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This news release contains "forward-looking statements" within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking statements. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "appears to be", "likely, "plans", "looks to", "possible", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". The forward-looking information and forward-looking statements contained herein include, but are not limited to, statements regarding: the closing of the transactions specified in the TLA, including but not limited to the share issaunces contemplated by the Company; potential increases by Carnance of its inventory; the future market data for the global automotive industry; the future products and performance of the Company; and the ability of the Company to continue adding innovative technologies to its portfolio.
Forward-looking information in this news release is based on certain assumptions and expected future events, namely: the satisfaction of the closing conditions in the TLA and receipt of all necessary approvals in order to complete the transactions contemplated therein; the ability of Carnance to increase its inventory as currenty contemplated or at all; customer interest at a level to drive future sales as currently contemplated or at all; the Company's ability to continue as a going concern; the commercial viability and growth in popularity of the Company's applications; the Company's ability to continue to develop and acquire revenue-generating applications; continued approval of the Company's activities by the relevant governmental and/or regulatory authorities; the continued development of the Company's technologies; the Company having sufficient funds to continue operations as planned; growth of the global automobile industry as currently anticipated or at all; the impact of growth of the global automotive industry on the Company's operations; and the continued growth of the Company in general.
These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: uncertainty with respect to the future growth of the global automobile industry and/or any other industry group or subset relevant to the Company's operations; uncertainty to predict the Company's ability to compete with other participants in the industries in which it operates; the potential inability of the Company to continue as a going concern; the risks associated with Software-as-a-Service ("SaaS") and technology industries in general; increased competition in the SaaS and technology markets in general; the potential future unviability of the Company's product offerings; risks associated with potential governmental and/or regulatory action with respect to the Company's activities; risks associated with a potential collapse in the value of SaaS services and the SaaS market; risks associated with the Company's ability to generate a profit; the inability of the Company to add innovative technologies to its portfolio; the Company not having adequate resources, financial and otherwise, as required to continue its operations as planned; and risks with respect to market demand for the Company's products. Furthermore, any market data presented in this press release is not indicative of the Company's future performance and in no way should be interpreted as such.
Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.
Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Xigem Technologies Corporation
On behalf of the Company:
Brian Kalish, Chief Executive Officer

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

MTL Cannabis Corp. Announces Shareholder Alignment Initiative
MTL Cannabis Corp. Announces Shareholder Alignment Initiative

Cision Canada

time10 hours ago

  • Cision Canada

MTL Cannabis Corp. Announces Shareholder Alignment Initiative

PICKERING, ON, June 6, 2025 /CNW/ - MTL Cannabis Corp. (CSE: MTLC) ("MTL" or the "Company") announced today its shareholder alignment initiatives through the implementation of a long-term incentive plan ("LTIP"). In connection with the approval of the LTIP, executive officers were granted restricted share units ("RSUs") and deferred share units ("DSUs"), with deferred vesting. This initiative reflects the Company's commitment to aligning the executive team interests with shareholders and to support retention and leadership stability. The grant was comprised of two million RSUs and three million DSUs, with the RSUs vesting annually in arrears over three years and the DSUs vesting on the third anniversary of the grant. About MTL Cannabis Corp. MTL Cannabis Corp. is the parent company of Montréal Medical Cannabis Inc. ("MTL Cannabis"), a licensed producer operating from a 57,000 sq ft licensed indoor grow facility in Pointe Claire, Québec; Abba Medix Corp., a licensed producer in Pickering, Ontario that operates a leading medical cannabis marketplace; IsoCanMed Inc., a licensed producer in Louiseville, Québec growing best-in-class indoor cannabis, in its 64,000 sq. ft. production facility; and Canada House Clinics Inc., operating clinics across Canada that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from simple and complex medical conditions. As a flower-first company built for the modern street, MTL Cannabis uses proprietary hydroponic growing methodologies supported by handcrafted techniques to produce products that are truly craft for the masses. MTL Cannabis focuses on craft quality cannabis products, including lines of dried flower, pre-rolls and hash marketed under the "MTL Cannabis", "Low Key by MTL" and "R'belle" brands for the Canadian market through nine distribution arrangements with various provincial cannabis distributors. MTL Cannabis has also developed several export channels for bulk and unbranded GACP quality cannabis. It is MTL's goal for Abba Medix Corp. to become the leading distributor of medical cannabis in Canada and for Canada House Clinics to be the leading Canadian provider of medical cannabis clinic services. For further information, please visit or the Company's public filings at Cautionary Statement Regarding Forward-Looking Information. This press release contains forward- looking statements, including statements that relate to, among other things, the Company's clinic, production and technology businesses, its future plans, the Company's markets, objectives, goals, strategies, intentions, beliefs, expectations and estimates, and can generally be identified by the use of words such as "may", "will", "could", "should", "would", "likely", "possible", "expect", "intend", "estimate", "anticipate", "believe", "plan", "objective" and "continue" (or the negative thereof) and words and expressions of similar import. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. Material assumptions used to develop forward-looking information in this news release include, the regulations related to cannabis use under the Cannabis Act (Canada); Company liquidity and capital resources, including the availability of additional capital resources to fund its activities and repay its outstanding indebtedness; level of competition; the ability to adapt products and services to the changing market; the ability to attract and retain key executives; the ability to execute strategic plans; continued integration of business unit, expansion activities at all our operating locations; and the leveraging of cash flow from operations to accelerate growth and further improve the Company's balance sheet. Additional information about material factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements may be found in the Company's Listing Statement dated August 14, 2023 and its most recent annual and interim Management's Discussion and Analysis under "Risk and Uncertainties" as well as in other public disclosure documents filed with Canadian securities regulatory authorities. The Company does not undertake any obligation to update publicly or to revise any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except as required by law.

Northern Shield Grants Stock Options
Northern Shield Grants Stock Options

Cision Canada

time10 hours ago

  • Cision Canada

Northern Shield Grants Stock Options

OTTAWA, ON, June 6, 2025 /CNW/ - Northern Shield Resources Inc. (" Northern Shield" or the " Company") (TSXV: NRN) announces that it has granted options to acquire a total of 2,220,000 common shares in the capital of the Company (" Common Shares") to its directors and officers and a further 210,000 to employees and consultants pursuant to its shareholder approved stock option plan (the " Stock Option Plan"). Each option entitles the holder to acquire one Common Share at an exercise price of $0.12 per Common Share until June 6, 2030. Following such grant, Northern Shield now has outstanding under its Stock Option Plan, options to acquire Common Shares equal to just under 8% of Northern Shield's currently outstanding Common Shares. About Northern Shield Resources Northern Shield Resources Inc. is a Canadian-based company known as a leader in generating high-quality exploration targets that views greenfield exploration as an opportunity to find a mineable deposit, near surface, and at relatively low cost. We implement a model driven exploration approach to reduce the risk associated with early-stage projects for ourselves, our shareholders, and the environment. This approach led us to option the Root & Cellar Property from a Newfoundland prospector, who discovered the mineralization, and then its advancement to a large gold-silver-tellurium system. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Minsud Announces Option Grant
Minsud Announces Option Grant

Cision Canada

time12 hours ago

  • Cision Canada

Minsud Announces Option Grant

TORONTO, June 6, 2025 /CNW/ - Minsud Resources Corp. (TSXV: MSR) (" Minsud" or the " Company") is pleased to announce that it has granted options to purchase an aggregate of 600,000 common shares of the Company (the " Stock Options") to certain directors of the Company. The Stock Options are exercisable at a price of $0.60 per share for a period of five years from the date of issuance. As of the date hereof, a total of 16,494,852 common shares of the Company are reserved for issuance under the Company's stock option plan and, after this new grant, 13,876,000 options will be outstanding. About Minsud Resources Corp. Minsud is a mineral exploration company focused on exploring its flagship Chita Valley Cu-Mo-Au-Ag-Pb-Zn Project, in the Province of San Juan, Argentina. The Company's shares are listed on the TSX-V under the trading symbol "MSR", and on the OTCQX under the symbol "MDSQF". Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. SOURCE Minsud Resources Corp.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store